[ARS] AYTU BIOPHARMA, INC SEC Filing

Filing Impact

(No impact)

Filing Sentiment

(Neutral)

Form Type

ARS

10/24/2025 - 04:04 PM

ARS - AYTU BIOPHARMA, INC

ARS Filing - AYTU BIOPHARMA, INC

This filing is available as a PDF document.

Filing Type: ARS

Company: AYTU BIOPHARMA, INC (AYTU)

Acceptance Date: 2025-10-24T16:04:27.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Aytu Biopharma Inc

NASDAQ:AYTU

AYTU Rankings

#5945 Ranked by Market Cap

N/A Ranked by Dividends

AYTU Latest News

Dec 15, 2025

Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults

Nov 24, 2025

Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference

Nov 13, 2025

Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results

Nov 5, 2025

Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025

Oct 28, 2025

Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)

AYTU Latest SEC Filings

Nov 13, 2025

[10-Q] AYTU BIOPHARMA, INC Quarterly Earnings Report

Nov 13, 2025

[8-K] AYTU BIOPHARMA, INC Reports Material Event

Oct 24, 2025

[DEF 14A] AYTU BIOPHARMA, INC Definitive Proxy Statement

Oct 20, 2025

[Form 5] AYTU BIOPHARMA, INC Annual Statement of Beneficial Ownership

Oct 7, 2025

[Form 4] AYTU BIOPHARMA, INC Insider Trading Activity

AYTU Stock Data

Market Cap 23.23M

Float 9.64M

Insiders Ownership 7.58%

Institutions Ownership 38.09%

Short Percent 5.17%

Industry Drug Manufacturers - Specialty & Generic

Sector Pharmaceutical Preparations

Website Link

Country United States

City DENVER